title: 3rd Pavia international symposium on advanced kidney cancer.
abstract: Kidney cancers' natural history has radically changed in the past few years, due to the development of novel targeted agents. Despite these improvements, several unanswered questions still remain on the table, regarding the best first-line treatment, the ideal sequence of treatments, the management of specific subgroups of patients (e.g., elderly patients or those with comorbidities) and the relevance of prognostic factors, among many others. To foster discussions among clinicians and investigators working in this field, and to exchange different viewpoints concerning the newest advances in kidney cancer pathogenesis and treatment, the 3rd Pavia International Symposium on Advanced Kidney cancer was held in Pavia (Italy) between 30 June and 1 July 2011. The aim of this report is to summarize the most significant advances in the different disciplines applied to advanced kidney cancer, which were presented and discussed during the meeting, and how these advances will be changing the perspective of patients with this disease.
authors.affiliation: I.R.C.C.S. San Matteo University Hospital Foundation, Medical Oncology ,  27100 Pavia ,  Italy.
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
authors.forename: Sergio
authors.initials: S
authors.lastname: Bracarda
mesh_terms: D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007680:Kidney Neoplasms / Q000737:chemistry / Q000175:diagnosis / Q000276:immunology / Q000473:pathology / Q000628:therapy; D058990:Molecular Targeted Therapy; D018579:Patient Selection; D057285:Precision Medicine; D011379:Prognosis; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor